MOLECULAR HEALTH INSIGHT
DEAD

Serial Number

87048032

Owner

Molecular Health GmbH

Attorney

Peter T. Wakiyama

Filing Date

May 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MOLECULAR HEALTH INSIGHT Trademark

Serial Number: 87048032

MOLECULAR HEALTH INSIGHT is a trademark filed by Molecular Health GmbH on May 24, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Molecular Health GmbH (44 trademarks)

Belfortstr. 2
Heidelberg 69115 , DE

Entity Type: 03

Trademark Details

Filing Date

May 24, 2016

Registration Date

Not Registered

Published for Opposition

May 16, 2017

Goods & Services

Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology; downloadable computer databases containing medical and health information on humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for mobile devices, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans; downloadable mobile applications for accessing databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology

Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes; providing access to online software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to non-downloadable computer software and algorithms for medical diagnostic and treatment purposes

Medical consulting services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical care, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols

Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, life sciences, genomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; consulting and research services in the nature of retrieval, integration, correlation, analysis and interpretation of genomic, sequencing, and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, medical health information patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; designing and developing searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information and records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for purposes of scientific, medical and pharmaceutical research; providing temporary use to non-downloadable applications for mobile devices, namely, smart phones and tablets, and web applications accessible through the internet providing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology for scientific research purposes; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; services for mobile devices, namely, smart phones and tablets, being software design; non-downloadable web applications for accessing databases accessible through the internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; providing temporary use of non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; medical research services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 18, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 17, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jul 11, 2019 EX4G
SOU EXTENSION 4 FILED
Jul 11, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2019 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 11, 2019 TCCA
SOU EXTENSION 3 GRANTED
Jan 11, 2019 EX3G
SOU EXTENSION 3 FILED
Jan 11, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 11, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jul 11, 2018 EX2G
SOU EXTENSION 2 FILED
Jul 11, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 11, 2018 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 11, 2018 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2018 EXRA
SOU EXTENSION 1 GRANTED
Feb 20, 2018 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 20, 2018 AITU
NOTICE OF REVIVAL - E-MAILED
Feb 5, 2018 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Feb 5, 2018 TPEX
PETITION TO REVIVE-GRANTED
Feb 5, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 5, 2018 PROA
SOU EXTENSION 1 FILED
Jan 11, 2018 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2016 NWOS
NEW APPLICATION ENTERED
May 27, 2016 NWAP